The research team, including Drs. Teresa Evans and Lindsay Bira of the University of Texas Health-San Antonio, described their results in the March issue of the journal Nature Biotechnology. The survey included clinically validated scales for anxiety and depression. Nine of 10 respondents were…
News
- Depression, anxiety high in graduate students
- Argonaut Gold Inc. (AR) Analysts See $0.04 EPS; Longwood Capital Partners Has Upped ...
Argonaut Gold Inc. (AR) Analysts See $0.04 EPS; Longwood Capital Partners Has Upped Assembly Biosciences (ASMB) Holding By $27.71 Million ... Mexico; the San Antonio gold project located in the State of Baja California Sur, Mexico; the San Agustin project situated in the State of Durango, Mexico…
- Copy of: FDA Approves At-Home Test for Breast Cancer
FDA Approves At-Home Test for Breast Cancer The biotech company 23andMe was given the green light to send customers the test , which gives them a report about three BRCA1/BRA2 gene mutations. The CDC says the BRCA mutations tend to be present in about 2 percent of Ashkenazi Jewish ...
- CellRight Technologies Signs Multi-Year Distribution Agreement With Arthrex, Inc.
SAN ANTONIO–(BUSINESS WIRE)–Tissue Regenix Group (AIM:TRX) (“Tissue Regenix” or “The Group”) the regenerative medical devices ... In August 2017 Tissue Regenix acquired CellRight Technologies®, a biotech company that specializes in regenerative medicine and is dedicated to the…
- Fate Therapeutics reports 4Q loss
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share. The clinical-stage biotech company that develops stem cell treatments posted revenue of $1 million in the period, meeting Street…